Skip to main content

Table 1 Baseline characteristics of patients enrolled in the study

From: Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study

Characteristic ITV group (n = 38) ITV + ITC group (n = 23) P
Sex (male) (n, %) 20, 52.63% 10, 43.48% 0.488
Age (years) 53.50 ± 15.17 55.00 ± 15.08 0.761
Primary disease (n, %)    0.091
 Cerebral hemorrhage 30, 78.95% 14, 60.87%  
 Craniocerebral trauma 4, 10.53% 2, 8.70%  
 Benign Intracranial tumor 4, 10.53% 7, 30.43%  
Comorbidities (n, %)    0.833
 Diabetes 3, 7.89% 4, 17.39%  
 Cardiovascular disease 11, 28.95% 9, 39.13%  
 Pulmonary disease 0, 0.00% 1, 4.35%  
 Nervous system disease 1, 2.63% 1, 4.35%  
Surgeries (n, %)    0.396
 Craniotomy evacuation of hematoma + decompressivecraniectomy 32, 84.21% 21, 91.27%  
 Intracranial tumor resection 3, 7.89% 2, 8.70%  
 Craniotomy aneurysm clipping 12, 31.58% 9, 39.13%  
 Drainage of intracranial hematoma 9, 23.68% 7, 30.43%  
 Ventricle peritoneal shunt 6, 15.79% 5, 21.74%  
 Lumbar cistern drainage 26, 68.42% 15, 65.22%  
 Ommaya reservoir 2, 5.26% 2, 8.70%  
Coinfection (n, %)    0.727
 Lung 29, 76.32% 18, 78.26%  
 Bloodstream 5, 13.16% 4, 17.39%  
SOFA score 5.34 ± 3.02 5.08 ± 2.23 0.707
APACHE II score 18.55 ± 5.62 17.65 ± 4.90 0.513
Clinical symptoms
 Fever (°C) 39.02 ± 0.53 39.17 ± 0.48 0.256
  1. SOFA sequential organ failure assessment, APACHE acute physiology and chronic health evaluation. ITV intravenous, ITV + ITC intrathecal/intracerebral